ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 0563 • ACR Convergence 2020

    Relation of Pain Sensitization to Isokinetic Knee Extension Torque: The MOST Study

    Patrick Corrigan1, Tuhina Neogi2, Laura Frey Law3, Neil Segal4, Michael Nevitt5, Beth Lewis6 and Joshua Stefanik1, 1Northeastern University, Boston, MA, 2Boston University School of Medicine, Boston, MA, 3University of Iowa, Iowa City, IA, 4University of Kansas Medical Center, Iowa City, IA, 5Department of Epidemiology and Biostatistics, University of California San Francisco, Orinda, CA, 6University of Alabama at Birmingham, Birmingham

    Background/Purpose: Central and local alterations in nociception are related to heightened pain severity and can be present in people who have knee osteoarthritis (OA). Yet,…
  • Abstract Number: 0577 • ACR Convergence 2020

    Qualitative Review of Unsuccessful Pilot Study of Super-Utilizer Systemic Lupus Erythematosus (SLE) Patients Enrollment into Team Based Program to Improve Patient Outcomes

    Sarah Min1, Devy Setyono2, Sunghye Kim3, Feben Girma1, Melanie Martin1 and Rachel Wolfe1, 1Wake Forest Baptist Medical Center, Winston-Salem, NC, 2Emkey Arthritis and Osteoporosis Clinic, Wyomissing, PA, 3W.G. Hefner VA Medical Center, Salisbury, NC

    Background/Purpose: SLE is a chronic multi-system autoimmune disease, affecting mostly women of child-bearing age and more racial minorities, with a wide spectrum of outcomes: from…
  • Abstract Number: 0576 • ACR Convergence 2020

    Medical Savings of Timely Rheumatoid Arthritis Diagnoses

    Kathryn Johnson1, Christine Sawicki1, Cristina Sotelo2, Tanvi Kalevar3, Sylvie Lardeux4, Fabio Casadio3, David Baghdadi5, Michele Hamburger6, Elisea Avalos-Reyes7 and Kjel Johnson1, 1CVS Health, Lincoln, RI, 2CVS Health, Austin, TX, 3CVS Health, New York, NY, 4CVS Health, Wellesley, MA, 5CVS Health, Woonsocket, RI, 6Frances Hamburger Institute, Hauppauge, NY, 7CVS Health, Irving, TX

    Background/Purpose: Previous studies suggest that early rheumatoid arthritis (RA) recognition and treatment provides greater clinical benefits than treatment started later in the disease course. However,…
  • Abstract Number: 0582 • ACR Convergence 2020

    Mortality and Cost of Hospitalization: Do Hospitals Caring for More SLE Patients Perform Better?

    Christine Anastasiou1, Laura Trupin1, Patricia Katz2, Zara Izadi3, Milena Gianfrancesco1, Gabriela Schmajuk4 and Jinoos Yazdany5, 1University of California, San Francisco, San Francisco, CA, 2University of California, San Francisco, Novato, CA, 3University of California San Francisco, San Francisco, CA, 4University of California, San Francisco, Atherton, CA, 5UCSF, San Francisco, CA

    Background/Purpose: Individuals with systemic lupus erythematosus (SLE) have an increased risk of hospitalization throughout their lifetime, potentially leading to higher patient mortality and healthcare costs.…
  • Abstract Number: 0581 • ACR Convergence 2020

    A Proposed Economic Framework to Model the Consequences of Psoriatic Arthritis Disease Domains

    Jacquelyn Chou1, Ervant Maksabedian2, David Collier3 and Howard Thom4, 1PRECISION heor, Los Angeles, CA, 2Amgen Inc., LOS ANGELES, CA, 3Amgen, Thousand Oaks, CA, 4University of Bristol, Bristol, England, United Kingdom

    Background/Purpose: Psoriatic arthritis (PsA) manifests heterogeneous signs and symptoms (e.g., dactylitis, enthesitis, axial involvement, skin- and nail disease), which may respond to treatments differently. While…
  • Abstract Number: 0587 • ACR Convergence 2020

    Barriers to Rheumatologic Care and Antimalarial Refills Among a Cohort of Patients with Systemic Lupus Erythematosus During the COVID-19 Pandemic

    Alfredo Aguirre1, Laura Trupin1, Sarah Patterson2, Kimberly DeQuattro2, Patricia Katz3, Cristina Lanata2, Stephanie Rush1, Lindsey Criswell4, Maria Dall'Era5 and Jinoos Yazdany1, 1University of California, San Francisco, San Francisco, CA, 2UCSF, San Francisco, CA, 3University of California, San Francisco, Novato, CA, 4Rosalind Russell/Ephraim P. Engleman Rheumatology Research Center, University of California San Francisco, San Francisco, CA, 5Division of Rheumatology, University of California, San Francisco, CA

    Background/Purpose: The pandemic of coronavirus disease 19 (COVID-19) has led to widespread disruptions across the spectrum of healthcare. We sought to investigate barriers to medical…
  • Abstract Number: 0589 • ACR Convergence 2020

    The Ideal Mhealth Application for Rheumatoid Arthritis: Qualitative Findings from Stakeholder Focus Groups

    Diederik De Cock1, Maryline Vandeputte2, Rani Van Melder2, Michael Doumen2, Delphine Bertrand1, Veerle Stouten1, Sofia Pazmino1, Rene Westhovens3 and Patrick Verschueren4, 1KU Leuven, Leuven, Belgium, 2KU Leuven, Leuven, 3University Hospitals Leuven, Belgium, Leuven, Belgium, 4University Hospital Leuven, Leuven, Belgium

    Background/Purpose: Early access to specialized rheumatological care is under increasing pressure. Many countries are currently confronted with a relative shortage of practicing rheumatologists, while recent…
  • Abstract Number: 0584 • ACR Convergence 2020

    Total Cost of Care for Patients with Rheumatoid Arthritis

    Kjel Johnson1, Rebecca Karos2, Elisea Avalos-Reyes3, Fabio Casadio4, Michele Hamburger5 and Chiara Leprai4, 1CVS Health, Lincoln, RI, 2CVS Health, Wellesley, MA, 3CVS Health, Irving, TX, 4CVS Health, New York, NY, 5Frances Hamburger Institute, Hauppauge, NY

    Background/Purpose: The range of medical costs associated with rheumatoid arthritis (RA) is, in part, related to the various treatment options. Treatment for RA focuses on…
  • Abstract Number: 0579 • ACR Convergence 2020

    Risk Factors of Nonadherence in New Rheumatoid Arthritis Patients

    Guy Cozzi1, Pavlo Kyrychenko2, Michele Hamburger3 and Elisea Avalos-Reyes4, 1CVS Health, Northbrook, IL, 2CVS Health, Norhtbrook, IL, 3Frances Hamburger Institute, Hauppauge, NY, 4CVS Health, Irving, TX

    Background/Purpose: Biologic disease-modifying antirheumatic drug (bDMARD) therapies are commonly prescribed for rheumatoid arthritis (RA) treatment. However, their high out-of-pocket (OOP) cost may limit patient access…
  • Abstract Number: 0592 • ACR Convergence 2020

    A Rheumatology-Driven Protocol and Treatment Algorithm of SARS-CoV-2 Cytokine Release Syndrome and Its Associated Outcomes

    Sandy Lee1, Neha Chiruvolu2, Muntarin Karim3, Patil Injean4, Loomee Doo5, Donna Jose6, Deepa Panikkath1, Micah Yu5, Anna Lafian5, Wendy De La Pena7, Albert Chow8, Karina Torralba9, Vaneet Sandhu10, Mehrnaz Hojjati5, Marven Cabling5 and Christina Downey1, 1Loma Linda University Medical Center, Redlands, CA, 2UC Riverside School of Medicine, Riverside, CA, 3Loma Linda University Health System, Loma Linda, CA, 4LOMA LINDA UNIVERSITY MEDICAL CENTER - RHEUMATOLOGY, Redlands, CA, 5Loma Linda University Medical Center, LOMA LINDA, CA, 6Loma Linda University Medical Center, Ontario, CA, 7PRCSG, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 8Loma Linda University, San Bernardino, CA, 9Loma Linda University School of Medicine, Redlands, CA, 10Loma Linda University, Loma Linda, CA

    Background/Purpose: The newly identified SARS-CoV-2 has brought Cytokine Release Syndrome (CRS) to a level of prominence not often seen in adult medicine. Mortality rates of…
  • Abstract Number: 0595 • ACR Convergence 2020

    High Satisfaction with Tele-medicine in a New York City Clinic

    Tommy Chen1, Cathy Guo1, Wei Tang1, Leila Khalili1 and Anca Askanase2, 1Columbia University Medical Center, New York, NY, 2Columbia University College of Physicians & Surgeons, New York, NY

    Background/Purpose: The face of medicine is changing with the time. A twenty-first century technological revolution in medicine happened in March 2020 as the COVID-19 pandemic…
  • Abstract Number: 0596 • ACR Convergence 2020

    Clinical Academic Rheumatology: A Boon for Health Systems

    Kathleena D'Anna1, Karina Torralba2, Christina Downey3 and Carlos Silva Lynch4, 1Loma Linda University Medical Center, Moreno Valley, CA, 2Loma Linda University School of Medicine, Redlands, CA, 3Loma Linda University Medical Center, Redlands, CA, 4Loma Linda University Medical Center, Loma Linda

    Background/Purpose: Finding a balance between clinical and scholarly productivity is a challenge for many academic clinician-educator (CE) rheumatologists. An examination of workload and practice-generated downstream…
  • Abstract Number: 0591 • ACR Convergence 2020

    Intervention to Improve SLE Medication Adherence Using Surescripts Pharmacy Refill Data

    Kai Sun1, Jennifer Rogers2, Rebecca Sadun3, Amanda Eudy3, Jayanth Doss3, Lisa Criscione-Schreiber4, Ann Cameron Barr5, Lena Eder6, Mithu Maheswaranathan3, Amy Corneli7, Hayden Bosworth1 and Megan Clowse8, 1Duke University Hospital, Durham, 2Duke University Hospital, Durham, DE, 3Duke University, Durham, NC, 4Division of Rheumatology and Clinical Immunology, Department of Medicine, Duke University Medical Center, Durham, NC, 5Duke University Hospital, Durham, NC, 6Duke University Hospital, Chapel Hill, NC, 7Duke University, Durham, 8Duke University, Chapel Hill, NC

    Background/Purpose: Medication nonadherence is as high as 80% among SLE patients and leads to higher morbidity, mortality, and healthcare costs. Few studies have tested interventions…
  • Abstract Number: 0599 • ACR Convergence 2020

    Evaluation of Telephone Consultations in Germany as an Additional Tool in Outpatient Rheumatology Clinics During the COVID-19 Pandemic

    Ulrich Drott1, Axel Braner1, Thomas Kollewe2, Harald Burkhardt3 and Florian Meier1, 1Department of Rheumatology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany, Frankfurt, Germany, 2J. W. Goethe-Universität Frankfurt, FB Medizin, Frankfurter Arbeitsstelle für Medizindidaktik, Frankfurt, Germany, Frankfurt, Germany, 3Department of Rheumatology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany, Frankfurt am Main, Germany

    Background/Purpose: The Covid-19 pandemic holds multiple challenges for the healthcare system. Quick adoptions and adjustments are the mainstays during these times. Hygiene management and plans…
  • Abstract Number: 0594 • ACR Convergence 2020

    Mechanical and Temperature Stress During Biologic Shipments to Rheumatology Patients

    Sarah Dill1, Elizabeth Cheng2, Kyle Brees2, John Carpenter3 and Liron Caplan2, 1University of Colorado, Denver, CO, 2Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, CO, 3University of Colorado Skaggs School of Pharmacy, Aurora, CO

    Background/Purpose: Biologic medications are expensive, and unfortunately their immunogenicity contributes to loss of efficacy over time. Protein particles may form as a result of medication…
  • « Previous Page
  • 1
  • …
  • 664
  • 665
  • 666
  • 667
  • 668
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology